Power Law company profile

Clinuvel Pharmaceuticals

Biotech & Life Sciences · Melbourne, Australia · Founded 2001 · IPO 2001 Unicorn

Global bio pharmaceutical developing drugs for severe skin disorder

Valuation

$149M

Market cap · May/2026

Revenue

$61M

Latest reported FY

EBITDA

$27M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Global footprint

Where Clinuvel Pharmaceuticals has talent and traffic

Workforce by country

10 countries with
team presence

🇬🇧 United Kingdom40.5%

🇦🇺 Australia24.9%

🇺🇸 United States13.7%

🇸🇬 Singapore10.3%

🇨🇭 Switzerland4.6%

Top 5 of 10 shown

Market sentiment

What the market is saying about Clinuvel Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Clinuvel Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Clinuvel Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles